Cullen/Frost Bankers, Inc. Takeda Pharmaceutical CO LTD Transaction History
Cullen/Frost Bankers, Inc.
- $7.21 Billion
- Q4 2024
A detailed history of Cullen/Frost Bankers, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 137 shares of TAK stock, worth $1,816. This represents 0.0% of its overall portfolio holdings.
Number of Shares
137Holding current value
$1,816% of portfolio
0.0%Shares
11 transactions
Others Institutions Holding TAK
# of Institutions
332Shares Held
68MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.2MShares$175 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$71 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$61.4 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$55.9 Million0.05% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.41MShares$45.2 Million0.02% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...